Canada· CA-DIN-02505851

LUXTURNA

A voretigene neparvovec product containing voretigene neparvovec, registered in Canada by NOVARTIS PHARMACEUTICALS CANADA INC. The same ATC class is registered in 13 of our 19 countries.

ATC S01XA27

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedLUXTURNAATCS01XA27REGISTER NO.CA-DIN-02505851PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Voretigene neparvovec is registered in 13 of 19 countries.

Countries holding a registration under ATC S01XA27 (voretigene neparvovec), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 8 of them publish a price we can compare per daily dose

Voretigene neparvovec · ATC S01XA27

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
VORETIGENE NEPARVOVEC
Manufacturer
NOVARTIS PHARMACEUTICALS CANADA INC
Country
Canada (CA)
ATC code
S01XA27
ATC class
Voretigene neparvovec
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b4a93917-1bf9-4166-97fb-a0b9a5f5d062
GET /v1/drugs/b4a93917-1bf9-4166-97fb-a0b9a5f5d062?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02505851",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "SUBRETINAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "S01XA27",
  "schedule": [
    "Schedule D",
    "Prescription"
  ],
  "drug_code": "99512",
  "strengths": [
    "5000000000000 VG"
  ],
  "ahfs_class": null,
  "substances": [
    "VORETIGENE NEPARVOVEC"
  ],
  "product_categorization": null
}

See everything about voretigene neparvovec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.